MOH — authorised 17 April 1998
- Marketing authorisation holder: ABBVIE
- Status: likely_approved
🇮🇱 Zemplar in Israel
MOH authorised Zemplar on 17 April 1998
Marketing authorisation
Zemplar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in Israel
Frequently asked questions
Is Zemplar approved in Israel?
Yes. MOH authorised it on 17 April 1998.
Who is the marketing authorisation holder for Zemplar in Israel?
ABBVIE holds the Israeli marketing authorisation.